Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 502

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 3
Chunk 502
---
None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408. 

 71Table of Contents

Item 6. Exhibits

ExhibitNumber Description Form File No. FilingDate FiledHerewith3.1 Articles of Incorporation, as amended 10-Q  001-38951  05/11/2023  3.2 Amended and Restated Bylaws 8-K 001-38951 04/21/2023 10.1 At-The-Market Offering Agreement, dated July 18, 2025, between Artelo Biosciences, Inc. and R.F. Lafferty & Co., Inc. (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K filed with the SEC on July 18, 2025) 8-K 001-38951 07/18/2025  10.2 Securities Purchase Agreement, dated June 24, 2025, between Artelo Biosciences, Inc. and the Purchasers named therein 8-K 001-38951 06/26/2025  10.3 Form of Subscription Agreement by and between Artelo Biosciences Inc. and the purchasers named therein 8-K 001-38951 05/01/2025  10.4 Form of Pre-Funded Warrant 8-K 001-38951 06/26/2025  10.5 Form of $5.82 Warrant 8-K 001-38951 06/26/2025  10.6 Form of $10.00 Warrant 8-K 001-38951 06/26/2025  10.7 Form of Convertible Note 8-K 001-38951 05/01/2025  10.8 Form of Warrant 8-K 001-38951 05/01/2025  31